Efficacy of omega-3 fatty acids in the treatment of carpal tunnel syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

TCTR

Registry ID

TCTR20160809001

Enrollment

Registered

2016-08-09

Start date

2016-08-08

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal tunnel syndrome Carpal tunnel syndrome Omega&#45

Interventions

Fish oil : EPA+DHA 1200 mg&#44

EPA:DHA 1:5,Fish oil : EPA+DHA 3000 mg&#44

EPA:DHA 1:5,methyl cellulose

Experimental Dietary Supplement,Experimental Dietary Supplement,Placebo Comparator Other

fish oil 1200,fish oil 3000,placebo

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. The patients with new diagnosis as carpal tunnel syndrome by clinical diagnosis criteria at Thammasat University Hospital. 2. Mild to moderate degree of CTS by electrodiagnostic criteria 3. 18-60 years old patients

Exclusion criteria

Exclusion criteria: 1. Carpal tunnel release or steroid injection 2. Supplement with omega-3 fatty acid within the last 3 months 3. Underlying diseases: bleeding tendency, diabetes mellitusand cervical radiculopathy 4. Take blood-thinning medications including warfarin (Coumadin), clopidogrel (Plavix), or aspirin 5. Allergy to fish oil and seafood 6. Pregnancy

Design outcomes

Primary

Measure	Time frame
NRS for numbness and pain change 3 months case record form	—

Secondary

Measure	Time frame
electrodiagnostic change 3 months electrodiagnostic study,BQ score change 3 months case record form	—

Countries

Thailand

Contacts

Public Contactsiranya paecharoen

Unaffiliated

pamu-jung@hotmail.com66899253659

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Efficacy of omega&#45;3 fatty acids in the treatment of carpal tunnel syndrome